Form 8-K - Current report:
SEC Accession No. 0001493152-24-037627
Filing Date
2024-09-20
Accepted
2024-09-20 16:45:13
Documents
16
Period of Report
2024-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50309
2 ex4-1.htm EX-4.1 20179
3 ex10-1.htm EX-10.1 215600
  Complete submission text file 0001493152-24-037627.txt   504300

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pure-20240916.xsd EX-101.SCH 3012
5 XBRL LABEL FILE pure-20240916_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pure-20240916_pre.xml EX-101.PRE 24163
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3245
Mailing Address 771 JAMACHA ROAD #512 EL CAJON CA 92019
Business Address 771 JAMACHA ROAD #512 EL CAJON CA 92019 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-14468 | Film No.: 241313907
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)